trending Market Intelligence /marketintelligence/en/news-insights/trending/upuotyuukhm1indfpublea2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Brooks Automation to acquire gene sequencing company GENEWIZ for $450M

Gold RRS 2020 — Top Gold Producers' Reserves In Decline

Infrastructure Issues: Understanding and Mitigating Risks

Trade Payment Risk Is Not Necessarily Default Risk

COVID-19: How can we tell which Local Governments will be most impacted by the Pandemic?

Brooks Automation to acquire gene sequencing company GENEWIZ for $450M

Brooks Automation Inc. agreed to acquire privately held GENEWIZ Group for about $450 million in cash, subject to adjustments.

South Plainfield, N.J.-based GENEWIZ provides gene sequencing and synthesis services.

Brooks Automation, which is funding the acquisition from cash on the balance sheet supplemented with incremental debt, said GENEWIZ is its largest life sciences acquisition to date and is expected to generate more than $140 million in revenue in the next 12 months.

The transaction is expected to close by the end of 2018, subject to customary closing conditions and regulatory approvals.

Evercore acted as exclusive financial adviser to Brooks Automation, with Mintz Levin Cohn Ferris Glovsky and Popeo as legal counsel. Jefferies LLC acted as financial adviser to GENEWIZ, with Shearman & Sterling as legal counsel.

Morgan Stanley Senior Funding Inc. is providing committed financing for the transaction.

Chelmsford, Mass.-based Brooks Automation provides automation and cryogenic solutions for multiple markets, including semiconductor manufacturing and life sciences.